Bioprinted organ models allow for rigorous pre-clinical testing of gender-specific medications, helping to identify potential adverse reactions before human trials begin. This increases the safety of clinical trials by providing a more comprehensive understanding of how a medication affects men and women differently.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.